Fact CheckerSign in

NCT05131035Recruiting

Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk

Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk in Adolescents at Clinical High Risk for Psychosis

Source: ClinicalTrials.gov · Last updated 24 Nov 2025

Brief summary (registry, in English)

This 10 week intervention, Specific Cognitive Remediation with Surround (or SCORES), is designed to target processing speed, a cognitive domain related directly to social functioning, which in turn, represents a vulnerability factor for psychosis. This remotely-delivered intervention combining targeted cognitive training exercises and group support was developed to directly impact processing speed, and at the same time, boost motivation and engagement in adolescents at risk for schizophrenia and other psychotic disorders.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
54 (estimated)
First submitted
11 Nov 2021
Start date
28 Oct 2021
Primary completion date
31 May 2026
Lead sponsor
Northwell Health
NCT number
NCT05131035

What you commit to

  • Study type: Interventional
  • Planned participants: 54
  • From 28 Oct 2021 to the primary completion date, 31 May 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Past or current history of a clinically significant central nervous system disorder (e.g., seizure disorder)
  • Significant visual or auditory impairment.

Other

  • Any DSM 5 Schizophrenia-Spectrum diagnosis
  • Non-English speaking
  • Estimated IQ\<70
  • Significant head injury
  • Significant substance abuse

Who the study is looking for

  • Meet Clinical High Risk (CHR) criteria on the Structured Interview for Psychosis Risk Syndromes, defined by the presence of at least one attenuated positive symptom at a moderate to severe level
  • A score representing 0.5 SD below the mean on Animal Naming, Trails A or BACS: Symbol Coding from the MATRICS Consensus Cognitive Battery (MCCB).

Age in the registry: 14 years to 20 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Northwell Health- The Zucker Hillside Hospital
Coordinator of this site? Confirm its status
Glen OaksUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.